Metoprolol, a widely employed β-adrenergic antagonist, is pivotal in cardiovascular pharmacology. Metoprolol is indicated primarily for conditions such as hypertension, angina pectoris, heart failure, and arrhythmias. The medication exerts its therapeutic effect by selectively inhibiting β-1 adrenergic receptors, resulting in diminished cardiac contractility, heart rate, and blood pressure. While generally well-tolerated, metoprolol may elicit adverse effects, including bradycardia, hypotension, and bronchospasm, necessitating vigilant patient monitoring. Contraindications encompass conditions such as severe bradycardia, heart block, and decompensated heart failure, warranting cautious use of alternative therapies. An adept understanding of metoprolol's multifaceted clinical profile empowers healthcare professionals to navigate treatment decisions judiciously, promoting favorable patient outcomes in cardiovascular management.
Copyright © 2024, StatPearls Publishing LLC.